A
Ashwani Sharma
Researcher at Academy of Scientific and Innovative Research
Publications - 9
Citations - 26
Ashwani Sharma is an academic researcher from Academy of Scientific and Innovative Research. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 1, co-authored 1 publications receiving 1 citations. Previous affiliations of Ashwani Sharma include Centre for Cellular and Molecular Biology.
Papers
More filters
Journal ArticleDOI
Late Endosomal/Lysosomal Accumulation of a Neurotransmitter Receptor in a Cellular Model of Smith-Lemli-Opitz Syndrome.
TL;DR: In this paper, a cellular model of Smith-Lemli-Opitz syndrome (SLOS) was generated in HEK-293 cells stably expressing the human serotonin1A receptor (an important neurotransmitter G-protein coupled receptor) using AY 9944, an inhibitor for the enzyme 3β-hydroxy-steroid-∆7 -reductase (7-DHCR).
Journal ArticleDOI
Nanocarrier-based approaches to combat chronic obstructive pulmonary disease.
TL;DR:
Journal ArticleDOI
Artificial Intelligence-Based Data-Driven Strategy to Accelerate Research, Development, and Clinical Trials of COVID Vaccine
Ashwani Sharma,Tarun Virmani,Vipluv Pathak,Anjali Sharma,Kamla Pathak,Girish Kumar Gupta and Vinod Kumar,Devender Pathak +6 more
TL;DR: The role of artificial intelligence in the field of clinical trials of vaccines and clinical practices using different tools is suggested and is more useful for the identification of potential existing drugs with inhibitory human coronavirus by using different datasets.
Journal ArticleDOI
Codelivery of Phytochemicals with Conventional Anticancer Drugs in Form of Nanocarriers
TL;DR: In this article , a review summarizes various phytochemicals employed in treatment of cancer, combination therapy of PHYCLO with conventional anticancer drugs and various nanotechnology-based carriers to deliver the combination therapy.
Journal ArticleDOI
Potential Effect of DPP-4 Inhibitors Towards Hepatic Diseases and Associated Glucose Intolerance
Ashwani Sharma,Tarun Virmani,Anjali Sharma,Vaishnavi Chhabra,Girish Kumar Gupta and Vinod Kumar,Kamla Pathak,Abdulsalam Alhalmi +6 more
TL;DR: The various effects of D PP-4 on the liver diseases like hepatitis C, non-alcoholic fatty liver, hepatic regeneration and stem cell, hepatocellular carcinoma, and the impact of elevated DPP-4 levels in association with liver diseases as a cause of glucose intolerance and their treatment drug of choices are discussed.